Home > Healthcare > Drug Device Combination > Therapeutic Systems > Flowable Hemostats Market
Flowable Hemostats Market size was valued at USD 723.8 million in 2023 and is anticipated to grow at a CAGR of 5.7% between 2024 and 2032. One of the primary drivers is the increasing number of surgeries and trauma cases, which has led to a higher demand for effective hemostatic agents to control bleeding.
Additionally, the rising prevalence of chronic diseases and the subsequent increase in surgical interventions have fueled the market growth. Further, the advancements in surgical techniques and the growing adoption of minimally invasive procedures have also contributed to the demand for flowable hemostats, as these products are often used to achieve hemostasis in such procedures. Furthermore, the development of innovative flowable hemostats with improved efficacy and safety profiles is also a significant factor contributing to market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Flowable Hemostats Market Size in 2023: | USD 723.8 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 5.7% |
2024 – 2032 Value Projection: | USD 1.2 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 117 |
Tables, Charts & Figures: | 210 |
Segments covered: | Origin, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Flowable hemostats are used to control bleeding during surgical procedures. They are typically delivered in a liquid or gel form and can be applied directly to the bleeding site. These hemostats work by promoting clot formation, which helps to seal off blood vessels and stop bleeding. Flowable hemostats are particularly useful in procedures where traditional methods such as sutures or pressure are not effective or feasible, such as in minimally invasive surgeries or surgeries involving delicate tissues.